NBIX
Neurocrine Biosciences, Inc.
NASDAQ · USHealthcareDrug Manufacturers - Specialty & Generic
$173.00+1.24%
Price as of Jul 20, 2026
NBIX valuation
Neurocrine Biosciences, Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- 22.76x
- P/E 2026E
- 29.90x
- P/E 2027E
- 22.93x
- P/E 2028E
- 17.72x
- P/S forward
- 4.62x
Trailing multiples
- P/E TTM
- 25.78x
- PEG TTM
- 1.95x
- Price / book
- 5.11x
- Price / sales
- 5.61x
- Price / cash flow
- 20.14x
Enterprise value
- Enterprise value
- $16.5B
- EV / sales
- 5.31x
- EV / EBITDA
- 17.25x
- EV / EBIT
- 21.09x
- Market cap
- $17.4B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.